SHANGHAI HI SILICON TECHNOLOGY CO., LTD.
SHANGHAI HI SILICON TECHNOLOGY CO., LTD.

Collagen Peptide: Major Process Improvements and Breakthroughs of High-market-share Well-known Brands in China and Globally

Table of Content [Hide]

    As a new type of foreign trade service provider driven by both technology transformation and foreign trade services, HiSiaddi has established a "1+2+3+4=1" service system and can supply raw materials from multiple well-known original manufacturers of Collagen Peptide. As a research and development-oriented foreign trade enterprise, HiSiaddi will objectively analyze multiple well-known domestic and international brands with high global market share and share their major technological progress and breakthroughs, enabling buyers to access authentic, up-to-date and valuable market information, unlike single-brand factories that only promote their own products.

    For more comprehensive and valuable Collagen Peptide market information, please contact HiSiaddi customer service.

    I. Industrialized Process & Indicator Breakthrough Upgrades of China’s Top 5 Export Brands (Ruibang Biology, Sinopharm Peptide Valley, Times Biology, Sichuan Huanxu, Zhongtai Biology, Industrialized Rollout 2025–2026)

    (I) Directed Composite Enzymatic Hydrolysis Breakthrough: Innovation in Molecular Weight Concentration and Biological Absorption Rate

    1. Breakthrough details: All 5 leading domestic brands have launched AI intelligent directed composite enzymatic hydrolysis patented production lines to replace traditional crude hydrolysis processes. Ruibang and Zhongtai achieve precise enzymatic cleavage with target bovine collagen peptide molecular weight locked within 800–1200 Da, narrowing molecular weight dispersion from the industry standard ±200 Da to within ±60 Da. Sinopharm Peptide Valley’s new patented bone extraction technology raises bovine bone collagen extraction yield from the traditional 62% to 81.3%. Times Biology integrates three-stage purification technology of reversed-phase separation, ion exchange and gel filtration to deliver measured hydroxyproline (core collagen efficacy indicator) ≥13.2%, far exceeding the national standard minimum limit of 11%. Sichuan Huanxu’s low-temperature dynamic extraction process stabilizes finished product purity at ≥99.2%.

    2. Benefits for downstream buyers: ① Raw materials require no secondary screening and purification, cutting downstream filtration and refining processing costs by 18%–25%; ② Formulation dosage of terminal health food and oral beverage raw materials can be reduced by 30% while meeting efficacy standards, lowering terminal formula material costs.

    3. Benefits for end consumers: Human absorption rate of small-molecule peptides rises from the conventional 62% to over 87%, shortening skin moisturization and joint care efficacy onset cycles by 40% at equal weight.

    (II) Low-temperature Activity Locking + Nano-encapsulation Modification Breakthrough: Improved High-temperature Resistance, Antioxidation and Shelf Life Indicators

    1. Breakthrough details: Sichuan Huanxu and Ruibang mass-produce nano-microcapsule encapsulation technology to resolve oxidation and browning pain points of bovine collagen peptide under high-temperature processing. All brands adopt negative-pressure low-temperature drying production lines below 42℃, raising finished product activity retention from the traditional 58% to over 94%, with residual activity ≥82% after high-temperature (120℃) baking and sterilization processing. Normal-temperature shelf life of products extends from 12 months to 24 months.

    2. Benefits for downstream buyers: Expandable application to three new tracks including high-temperature baked meal replacement bars, sterilized oral liquids and extruded functional food; reduced storage waste with raw material scrapping rates falling from 7% to 1.9%.

    3. Benefits for end consumers: Greatly improved formula stability of functional snacks and ready-to-drink collagen beverages, with a 75% drop in customer complaints regarding abnormal odor and stratification deterioration.

    (III) Green Pre-treatment Process Breakthrough: Dramatically Optimized Heavy Metal and Solvent Residue Indicators

    1. Breakthrough details: Ruibang’s patented 30-stage low-temperature degreasing cleaning process and Sinopharm Peptide Valley’s harmless bovine bone pre-treatment patent reduce lead, arsenic and cadmium heavy metal residues to <0.02ppm (3 times better than EU EC10/2011 food raw material limit standards) with undetectable organic solvents. All brands cut wastewater discharge by 42% and pass EU REACH and US FDA food raw material access audits.

    2. Benefits for downstream buyers: Raw materials directly qualify for European and American health food and cosmetic filings, eliminating third-party heavy metal re-inspection fees and shortening import customs clearance cycles by 5–7 working days.

    3. Benefits for end consumers: Medical-grade clean raw materials are compatible with medical beauty dressings and post-operative repair products, improving safety for sensitive skin and high-risk oral populations.

    (IV) Mass Production Breakthrough of Custom Segmented Peptides: Large-scale Launch of Efficacy-specific Peptides

    1. Breakthrough details: Times Biology and Zhongtai realize mass production of dipeptide/tripeptide enrichment through directional enrichment of Gly-Pro-Hyp active characteristic peptides, raising active dipeptide content 28 times higher than general raw materials. Two customized raw material categories are segmented: skin-specialized (Type I collagen enriched) and joint-specialized (small-molecule bone collagen).

    2. Benefits for downstream buyers: Direct OEM production of segmented efficacy-specific single products without independent compound R&D investment, shortening new product launch cycles by 60%.

    II. Cutting-edge Technological Breakthroughs and Indicator Upgrades of the World’s Top 5 Global Market-share Overseas Brands (GELITA Germany, Rousselot France, Nitta Japan, Lapi Italy, Vital Proteins USA, 2025–2026)

    (I) High-activity Characteristic Peptide Purification Breakthrough: Disruptive Optimization of Efficacy Equivalent Indicators

    1. Breakthrough details: GELITA and Nitta Gelatin complete mass production of clinical-grade dipeptide enrichment, with active characteristic dipeptide concentration 30 times higher than standard bovine collagen raw materials. Clinical trials verify 2.5g enriched peptide delivers equivalent efficacy to 10g conventional collagen, boosting efficacy equivalent by 4 times with multi-center human randomized controlled clinical trial filings completed. Rousselot upgrades membrane chromatography purification lines to achieve ash content ≤0.15%, meeting injectable-grade raw material benchmarks.

    2. Benefits for downstream buyers: 75% reduction in single-formula dosage for high-end health food, simultaneous reduction of capsule and powder carrier auxiliary materials, cutting terminal single-product production costs by 32%.

    3. Benefits for end consumers: Launch of low-dose portable collagen products with daily intake reduced from 10g to 2.5g, lifting product repurchase rates.

    (II) Sustainable Traceability + Low-allergen Process Breakthrough: Full-chain Gluten-free and Traceability Indicators Launched

    1. Breakthrough details: Vital Proteins and Lapi Gelatine roll out pasture GPS full traceability systems with grass-fed bovine raw materials traceable to breeding pastures. All brands achieve mass production with gluten content <5ppm complying with new US GFCO gluten-free certification regulations to avoid FDA gluten labeling penalties. GELITA’s low-carbon extraction process cuts water consumption by 37%, meeting EU 2030 carbon neutrality pre-standard carbon emission targets.

    2. Benefits for downstream buyers: Products qualify for European and American gluten-free health food tracks, exempt from special import gluten sampling inspections and eligible for high-end supermarket health line access.

    3. Benefits for end consumers: Gluten-sensitive populations can safely consume collagen products, expanding target consumer groups for end products.

    (III) Native Non-denatured Collagen Modification Breakthrough: Upgraded Physical and Chemical Indicators of Medical Dressing Raw Materials

    1. Breakthrough details: Rousselot and affiliated Bioiberica brands optimize non-denatured Type II bovine collagen modification technology, raising collagen fiber crosslink stability by 55% with water absorption and biocompatibility meeting medical wound dressing raw material standards, breaking the application barrier preventing traditional hydrolyzed collagen from wound repair use.

    2. Benefits for downstream buyers: Raw materials expand into medical consumables, enabling buyers to launch medical beauty dressing and medical patch product lines and raise product premium margins.

    III. Universal Industrial Chain Benefits Brought by Shared Technological Breakthroughs of All Categories (Common Upgrades for Domestic and Imported Leading Brands)

    (I) Raw Material Cost Benefits for Buyers

    New-process raw materials from domestic leading brands deliver a 21% reduction in comprehensive production costs; equivalent-grade domestic raw materials carry quotes 27% lower than European and American imported alternatives, cutting comprehensive centralized procurement costs for overseas buyers by 15%–22%. Custom raw material minimum order quantities drop from the traditional 5 tons to 1 ton, drastically lowering small-batch R&D trial production thresholds for small and medium buyers.

    (II) End Product Benefits for Brand Owners & Consumers

    1. Buyer side: Raw material application scope expands beyond traditional powder and oral liquid to four new tracks including high-temperature baked goods, medical dressings, cosmetic serums and sports nutrition, expanding product categories by over 40%.

    2. End consumer side: Major pain points of product absorption, safety and stability are resolved, lifting average end-product repurchase rates by 22% and reducing terminal brand compensation losses.

    For more comprehensive and valuable Collagen Peptide market information, please contact HiSiaddi customer service.


    References
    We use cookies to optimise and personalise your experience, but you can choose to opt out of non-essential cookies.
    To find out more, read our Privacy Policy
    Reject All
    Accept All